세계의 대동맥류 시장 - 규모, 점유율, 동향 분석 보고서 : 유형별, 치료법별, 제품별, 최종 용도별, 지역별 부문 예측(2025-2033년)

Aortic Aneurysm Market Summary

The global aortic aneurysm market size was estimated at USD 4.53 billion in 2024 and is projected to reach USD 12.87 billion by 2033, growing at a CAGR of 12.44% from 2025 to 2033. The market growth is driven by the increasing prevalence of aortic aneurysms, fueled by aging populations and common risk factors such as hypertension, smoking, and atherosclerosis.

In addition, the growing adoption of minimally invasive endovascular repair procedures, expansion of screening programs for early detection, and continuous advancements in stent graft technologies are accelerating market growth. In February 2025, Czechia launched a pilot abdominal aortic aneurysm (AAA) screening programme for men aged 65-67, aiming to detect AAAs early and prevent up to 100 deaths annually.

The increasing prevalence of cardiovascular disease among older populations drives demand in the aortic aneurysm industry. The incidence of abdominal aortic aneurysms (AAA) is increased by obesity, smoking, and high blood pressure. The need for endovascular and surgical procedures for screening, diagnosis, and intervention is increasing for healthcare systems.In September 2024, according to Medscape, AAA prevalence in the U.S. ranged from 0.5% to 3.2%, with ruptures causing approximately 15,000 deaths annually; globally.

Treatment options are being enhanced by developments in thoracic endovascular aneurysm repair (TEVAR) and endovascular aneurysm repair (EVAR). Flexibility, deployment precision, and compatibility with complex structures are all enhanced by new stent graft designs. Physician adoption of these devices is growing steadily, and they speed up recovery and lower complications. In November 2024, Bentley reported that its BeFlared bridging stent for FEVAR was effectively implanted, reducing procedure time and preserving artery blood flow.

Screening and prevention programs are increasing diagnosis rates. National AAA screening efforts in Europe and North America, combined with wider use of ultrasound and CT angiography, are enabling earlier detection in high-risk groups. This drives timely treatment, lowers rupture-related mortality, and sustains demand for surgical and endovascular solutions.In September 2025, using quick ultrasounds to identify aneurysms early, stop ruptures, and enhance outcomes for the 20,000 Canadians affected each year, Ontario started the country's first AAA screening program for people 65 and older.

Global Aortic Aneurysm Market Report Segmentation

This report forecasts volume & revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global aortic aneurysm market report based on type, treatment, product, end-use, and region:

• Type Outlook (Revenue USD Million, 2021 - 2033)
• Thoracic Aortic Aneurysm (TAA)
• Abdominal Aortic Aneurysm (AAA)
• Treatment Outlook (Revenue USD Million, 2021 - 2033)
• Open Surgical Repair (OSR)
• Endovascular Aneurysm Repair (EVAR)
• Thoracic Endovascular Aneurysm Repair (TEVAR)
• Fenestrated Endovascular Aneurysm Repair (FEVAR)
• Branched Endovascular Aneurysm Repair (BEVAR)
• Hybrid procedures
• Product Outlook ((Revenue, USD Million, 2021 - 2033)
• Aortic Stent Grafts
  • Bifurcated Stent Grafts (Standard EVAR)
  • Straight Stent Grafts (Standard TEVAR)
  • Fenestrated Stent Grafts (FEVAR)
  • Branched Stent Grafts (BEVAR)
  • Hybrid Stent Grafts
• Aortic Surgical Grafts
• Aortic Repair Accessory Devices
  • Guidewires
  • Diagnostic Catheters
  • Sheaths
  • Guiding Catheters
  • Molding Balloons
• End-use Outlook (Revenue USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers (ASC)
• Clinics
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Treatment outlook
  • 2.2.3. Product outlook
  • 2.2.4. End use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Global Aortic Aneurysm Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Global Aortic Aneurysm: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Case Study Analysis
• 3.5. Technology Landscape
• 3.6. Company Categorization
• 3.7. Setbacks Driving Unplanned Market Exits
• 3.8. Pipeline Product Analysis
• 3.9. Product Approvals
• 3.10. Pricing Trend Analysis

Chapter 4. Global Aortic Aneurysm Market Segment Analysis, By Type, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Type Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Aortic Aneurysm Market, by Type, 2021 to 2033
• 4.5. Thoracic Aortic Aneurysm (TAA)
  • 4.5.1. Thoracic Aortic Aneurysm (TAA) market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Abdominal Aortic Aneurysm (AAA)
  • 4.6.1. Abdominal Aortic Aneurysm (AAA) market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Aortic Aneurysm Market Segment Analysis, By Treatment, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Treatment Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Aortic Aneurysm Market, by Treatment, 2021 to 2033
• 5.5. Open Surgical Repair (OSR)
  • 5.5.1. Open surgical repair (OSR) market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Endovascular Aneurysm Repair (EVAR)
  • 5.6.1. Endovascular aneurysm repair (EVAR) market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Thoracic Endovascular Aneurysm Repair (TEVAR)
  • 5.7.1. Thoracic endovascular aneurysm repair (TEVAR) market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Fenestrated Endovascular Aneurysm Repair (FEVAR)
  • 5.8.1. Fenestrated endovascular aneurysm repair (FEVAR) market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.9. Branched Endovascular Aneurysm Repair (BEVAR)
  • 5.9.1. Branched endovascular aneurysm repair (BEVAR) market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.10. Hybrid Procedures
  • 5.10.1. Hybrid procedures market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Global Aortic Aneurysm Market Segment Analysis, By Product 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. Product Market Share Analysis, 2024 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Aortic Aneurysm Market, by Product, 2021 to 2033
• 6.5. Aortic Stent Grafts
  • 6.5.1. Aortic stent grafts market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.2. Aortic stent grafts by average selling price estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.3. Aortic stent grafts by unit volume 2021 - 2033 (Units)
  • 6.5.4. Bifurcated Stent Grafts (Standard EVAR)
    • 6.5.4.1. Bifurcated stent grafts (Standard EVAR) market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.4.2. Bifurcated stent grafts by average selling price estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.4.3. Bifurcated stent grafts by unit volume 2021 - 2033 (Units)
  • 6.5.5. Straight stent grafts (Standard TEVAR)
    • 6.5.5.1. Straight stent grafts (Standard TEVAR) market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.5.2. Straight stent grafts (Standard TEVAR) by average selling price estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.5.3. Straight stent grafts (Standard TEVAR) by unit volume 2021 - 2033 (Units)
  • 6.5.6. Fenestrated stent grafts (FEVAR)
    • 6.5.6.1. Fenestrated stent grafts (FEVAR) market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.6.2. Fenestrated stent grafts (FEVAR) by average selling price estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.6.3. Fenestrated stent grafts (FEVAR) by unit volume 2021 - 2033 (Units)
  • 6.5.7. Branched stent grafts (BEVAR)
    • 6.5.7.1. Branched stent grafts (BEVAR) market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.7.2. Branched stent grafts (BEVAR) by average selling price estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.7.3. Branched stent grafts (BEVAR) by unit volume 2021 - 2033 (Units)
  • 6.5.8. Hybrid stent grafts
    • 6.5.8.1. Hybrid stent grafts market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.8.2. Hybrid stent grafts by average selling price estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.8.3. Hybrid stent grafts by unit volume 2021 - 2033 (Units)
• 6.6. Aortic Surgical Grafts
  • 6.6.1. Aortic surgical grafts market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.2. Aortic surgical grafts by average selling price estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.3. Aortic surgical grafts by unit volume 2021 - 2033 (Units)
• 6.7. Aortic Repair Accessory Devices
  • 6.7.1. Aortic repair accessory devices market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7.2. Guidewires
    • 6.7.2.1. Guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7.3. Diagnostic catheters
    • 6.7.3.1. Diagnostic catheters market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7.4. Sheaths
    • 6.7.4.1. Sheaths market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7.5. Guiding catheters
    • 6.7.5.1. Guiding catheters market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7.6. Molding balloons
    • 6.7.6.1. Molding balloons market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Global Aortic Aneurysm Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 7.1. Definition and Scope
• 7.2. End Use Market Share Analysis, 2024 & 2033
• 7.3. Segment Dashboard
• 7.4. Global Aortic Aneurysm Market, by End Use 2021 to 2033
• 7.5. Hospitals
  • 7.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.6. Ambulatory Surgical Centers
  • 7.6.1. Ambulatory surgical centers market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.7. Clinics
  • 7.7.1. Clinics market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Aortic Aneurysm Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 8.1. Regional Market Share Analysis, 2024 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Regional Market Snapshot
• 8.4. Aortic Aneurysm Market Share by Region, 2024 & 2033:
• 8.5. North America
  • 8.5.1. North America aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory Scenario
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. U.S. aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory Scenario
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Canada aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Regulatory Scenario
    • 8.5.4.3. Competitive Scenario
    • 8.5.4.4. Mexico aortic aneurysm market, 2021 - 2033 (USD Million)
• 8.6. Europe
  • 8.6.1. Europe aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.6.2. UK
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory Scenario
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. UK aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.6.3. Germany
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory Scenario
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Germany aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.6.4. France
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory Scenario
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. France aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory Scenario
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Italy aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.6.6. Spain
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Regulatory Scenario
    • 8.6.6.3. Competitive Scenario
    • 8.6.6.4. Spain aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.6.7. Norway
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Regulatory Scenario
    • 8.6.7.3. Competitive Scenario
    • 8.6.7.4. Norway aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.6.8. Sweden
    • 8.6.8.1. Key Country Dynamics
    • 8.6.8.2. Regulatory Scenario
    • 8.6.8.3. Competitive Scenario
    • 8.6.8.4. Sweden aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.6.9. Denmark
    • 8.6.9.1. Key Country Dynamics
    • 8.6.9.2. Regulatory Scenario
    • 8.6.9.3. Competitive Scenario
    • 8.6.9.4. Denmark aortic aneurysm market, 2021 - 2033 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key Country Dynamics
    • 8.7.1.2. Regulatory Scenario
    • 8.7.1.3. Competitive Scenario
    • 8.7.1.4. Japan aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Scenario
    • 8.7.2.3. Competitive Scenario
    • 8.7.2.4. China aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Regulatory Scenario
    • 8.7.3.3. Competitive Scenario
    • 8.7.3.4. India aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Regulatory Scenario
    • 8.7.4.3. Competitive Scenario
    • 8.7.4.4. Australia aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Regulatory Scenario
    • 8.7.5.3. Competitive Scenario
    • 8.7.5.4. South Korea aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Regulatory Scenario
    • 8.7.6.3. Competitive Scenario
    • 8.7.6.4. Thailand aortic aneurysm market, 2021 - 2033 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key Country Dynamics
    • 8.8.1.2. Regulatory Scenario
    • 8.8.1.3. Competitive Scenario
    • 8.8.1.4. Brazil aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Scenario
    • 8.8.2.3. Competitive Scenario
    • 8.8.2.4. Argentina aortic aneurysm market, 2021 - 2033 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key Country Dynamics
    • 8.9.1.2. Regulatory Scenario
    • 8.9.1.3. Competitive Scenario
    • 8.9.1.4. South Africa aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key Country Dynamics
    • 8.9.2.2. Regulatory Scenario
    • 8.9.2.3. Competitive Scenario
    • 8.9.2.4. Saudi Arabia aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key Country Dynamics
    • 8.9.3.2. Regulatory Scenario
    • 8.9.3.3. Competitive Scenario
    • 8.9.3.4. UAE aortic aneurysm market, 2021 - 2033 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key Country Dynamics
    • 8.9.4.2. Regulatory Scenario
    • 8.9.4.3. Competitive Scenario
    • 8.9.4.4. Kuwait aortic aneurysm market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Profiles
  • 9.3.1. Medtronic
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Product benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. W.L. Gore & Associates, Inc.
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. Cook
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. MicroPort Scientific Corporation
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Boston Scientific Corporation
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Artivion Inc.
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Cardiatis
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Endologix Inc.
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Braile Biomedica
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Lombard Medical
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. INVAMED
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives